Urokinase and its receptor: marker of malignancy?

[1]  M. Duffy.  Urokinase-type plasminogen activator and malignancy , 1993 .

[2]  A. Sumiyoshi,et al.  The content of urokinase‐type plasminogen activator antigen as a prognostic factor in urinary bladder cancer , 1992, International journal of cancer.

[3]  K. Sugimachi,et al.  Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma. , 1991, Cancer research.

[4]  R. Schultz,et al.  Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. , 1990, Cancer research.

[5]  E. Appella,et al.  The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. , 1990, The Journal of biological chemistry.

[6]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.

[7]  M. Schmitt,et al.  UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCER , 1989, The Lancet.

[8]  M. Scully,et al.  Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. , 1989, The Journal of biological chemistry.

[9]  T. Salo,et al.  Proteolytic degradation of extracellular matrix in tumor invasion. , 1987, Biochimica et biophysica acta.

[10]  K. Burnand,et al.  Urokinase: the Enzyme Responsible for Invasion and Metastasis in Human Breast Carcinoma? , 1987 .

[11]  G. Cassani,et al.  Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. , 1986, The Journal of biological chemistry.

[12]  J. Plescia,et al.  The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type , 1986, The Journal of cell biology.

[13]  P. Gaffney,et al.  Plasminogen activators in human colorectal neoplasia. , 1986, British medical journal.

[14]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[15]  L. Holmberg,et al.  Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture , 1976, Nature.

[16]  E. Gorelik.  Protective effect of fibrin on tumour metastasis , 1992 .

[17]  G. Markus,et al.  Plasminogen activator activity and composition in human breast cancer. , 1982, Cancer research.